Global Registration Trial of Efficacy and Safety of CTL019 in Pediatric and Young Adult Patients with Relapsed/Refractory (R/R) Acute Lymphoblastic Leukemia (ALL): Update to the Interim Analysis

Published

Conference Paper

Full Text

Published version (via Digital Object Identifier)

Duke Authors

Martin, Paul Langlie

Cited Authors

Buechner, J; Grupp, SA; Maude, SL; Boyer, M; Bittencourt, H; Laetsch, TW; Bader, P; Verneris, MR; Stefanski, H; Myers, GD; Qayed, M; Pulsipher, MA; De Moerloose, B; Hiramatsu, H; Schlis, K; Davis, K; Martin, PL; Nemecek, E; Peters, C; Wood, P; Taran, T; Mueller, KT; Zhang, Y; Rives, S

Published Date

September 2017

Published In

Clinical Lymphoma, Myeloma & Leukemia

Volume / Issue

17 /

Start / End Page

S263 - S264

Published By

Elsevier BV

International Standard Serial Number (ISSN)

2152-2650

Digital Object Identifier (DOI)

10.1016/j.clml.2017.07.030